<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Patient.info PatientProfessionalArticle</title>
    <atom:link href="https://patient.info/doctor/rss" rel="self" type="application/xml"/>
    <link>https://patient.info/doctor/rss</link>
    <description>Latest updates from Patient.info PatientProfessionalArticle</description>
    <copyright>Copyright 2026 Patient.info</copyright>
    
        <item>
  <title>Field Safety Notices: 20 to 24 July 2026</title>
  <description></description>
  <author>Medicines and Healthcare products Regulatory Agency (MHRA)</author>
  <link>https://patient.info/doctor/drug-device-alert/field-safety-notices-20-to-24-july-2026</link>
  <guid>2Ih6o3sOQBprCBt5H3UPLb</guid>
  <pubDate>2026-07-28T10:57:23.000Z</pubDate>
  <enclosure 
    url="https://ogcdn.net/9d266224-4307-4b9d-b73f-00c1bdbd4759/v9/Field%20Safety%20Notices%3A%2020%20to%2024%20July%202026/rgba(188%2C%2049%2C%20123%2C%201)/og.png" 
    type="image/jpeg" 
    length="0" />
</item>

        <item>
  <title>399 - NHS Primary Care Bulletin - 23 July 2026</title>
  <description></description>
  <author>Thomas Andrew Porteus, MBCS</author>
  <link>https://patient.info/doctor/nhs-bulletin/399</link>
  <guid>1d4FJu5V6aNoWzVOCzwfmD</guid>
  <pubDate>2026-07-23T15:18:34.000Z</pubDate>
  <enclosure 
    url="https://ogcdn.net/9d266224-4307-4b9d-b73f-00c1bdbd4759/v9/399%20-%20NHS%20Primary%20Care%20Bulletin%20-%2023%20July%202026/rgba(188%2C%2049%2C%20123%2C%201)/og.png" 
    type="image/jpeg" 
    length="0" />
</item>

        <item>
  <title>Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets, EL(26)A/36</title>
  <description></description>
  <author>Medicines and Healthcare products Regulatory Agency (MHRA)</author>
  <link>https://patient.info/doctor/drug-device-alert/class-4-medicines-defect-notification-neuraxpharm-uk-ltd-tuzulby-prolonged-release-chewable-tablets-el-26-a-slash-36</link>
  <guid>6BgLmEcC3BONCLdji31xGX</guid>
  <pubDate>2026-07-23T10:03:27.000Z</pubDate>
  <enclosure 
    url="https://ogcdn.net/9d266224-4307-4b9d-b73f-00c1bdbd4759/v9/Class%204%20Medicines%20Defect%20Notification%3A%20Neuraxpharm%20UK%20Ltd%2C%20Tuzulby%20prolonged-release%20chewable%20tablets%2C%20EL(26)A%2F36/rgba(188%2C%2049%2C%20123%2C%201)/og.png" 
    type="image/jpeg" 
    length="0" />
</item>

        <item>
  <title>Domperidone: new contraindication in patients with phaeochromocytoma due to the risk of severe hypertension</title>
  <description></description>
  <author>Medicines and Healthcare products Regulatory Agency (MHRA)</author>
  <link>https://patient.info/doctor/drug-device-alert/domperidone-new-contraindication-in-patients-with-phaeochromocytoma-due-to-the-risk-of-severe-hypertension</link>
  <guid>BneupAKVIV9SraSe55jKN</guid>
  <pubDate>2026-07-21T13:00:37.000Z</pubDate>
  <enclosure 
    url="https://ogcdn.net/9d266224-4307-4b9d-b73f-00c1bdbd4759/v9/Domperidone%3A%20new%20contraindication%20in%20patients%20with%20phaeochromocytoma%20due%20to%20the%20risk%20of%20severe%20hypertension/rgba(188%2C%2049%2C%20123%2C%201)/og.png" 
    type="image/jpeg" 
    length="0" />
</item>

        <item>
  <title>Field Safety Notices: 13 to 17 July 2026</title>
  <description></description>
  <author>Medicines and Healthcare products Regulatory Agency (MHRA)</author>
  <link>https://patient.info/doctor/drug-device-alert/field-safety-notices-13-to-17-july-2026</link>
  <guid>6n2yuVswwb4rkVSvcNEqq0</guid>
  <pubDate>2026-07-21T08:16:08.000Z</pubDate>
  <enclosure 
    url="https://ogcdn.net/9d266224-4307-4b9d-b73f-00c1bdbd4759/v9/Field%20Safety%20Notices%3A%2013%20to%2017%20July%202026/rgba(188%2C%2049%2C%20123%2C%201)/og.png" 
    type="image/jpeg" 
    length="0" />
</item>

        <item>
  <title>Class 4 Medicines Defect Notification: Macarthys Laboratories Ltd T/A Martindale Pharma, Xaggitin XL Prolonged-release Tablets, EL(26)A/35</title>
  <description></description>
  <author>Medicines and Healthcare products Regulatory Agency (MHRA)</author>
  <link>https://patient.info/doctor/drug-device-alert/class-4-medicines-defect-notification-macarthys-laboratories-ltd-t-slash-a-martindale-pharma-xaggitin-xl-prolonged-release-tablets-el-26-a-slash-35</link>
  <guid>3nChtoj7L4NsObiRP1TwZV</guid>
  <pubDate>2026-07-20T13:01:18.000Z</pubDate>
  <enclosure 
    url="https://ogcdn.net/9d266224-4307-4b9d-b73f-00c1bdbd4759/v9/Class%204%20Medicines%20Defect%20Notification%3A%20Macarthys%20Laboratories%20Ltd%20T%2FA%20Martindale%20Pharma%2C%20Xaggitin%20XL%20Prolonged-release%20Tablets%2C%20EL(26)A%2F35/rgba(188%2C%2049%2C%20123%2C%201)/og.png" 
    type="image/jpeg" 
    length="0" />
</item>

        <item>
  <title>398: Primary Care Bulletin - NHS Updates for 16 July 2026</title>
  <description></description>
  <author>Thomas Andrew Porteus, MBCS</author>
  <link>https://patient.info/doctor/nhs-bulletin/398</link>
  <guid>iO3DScQsbzcba6MhFOZBj</guid>
  <pubDate>2026-07-16T15:34:39.000Z</pubDate>
  <enclosure 
    url="https://ogcdn.net/9d266224-4307-4b9d-b73f-00c1bdbd4759/v9/398%3A%20Primary%20Care%20Bulletin%20-%20NHS%20Updates%20for%2016%20July%202026/rgba(188%2C%2049%2C%20123%2C%201)/og.png" 
    type="image/jpeg" 
    length="0" />
</item>

        <item>
  <title>Botulinum toxin type A products: updated warnings regarding risk of iatrogenic botulism</title>
  <description></description>
  <author>Medicines and Healthcare products Regulatory Agency (MHRA)</author>
  <link>https://patient.info/doctor/drug-device-alert/botulinum-toxin-type-a-products-updated-warnings-regarding-risk-of-iatrogenic-botulism</link>
  <guid>4uESj1UddTsi3mkiKWY2ci</guid>
  <pubDate>2026-07-15T13:00:15.000Z</pubDate>
  <enclosure 
    url="https://ogcdn.net/9d266224-4307-4b9d-b73f-00c1bdbd4759/v9/Botulinum%20toxin%20type%20A%20products%3A%20updated%20warnings%20regarding%20risk%20of%20iatrogenic%20botulism/rgba(188%2C%2049%2C%20123%2C%201)/og.png" 
    type="image/jpeg" 
    length="0" />
</item>

        <item>
  <title>Field Safety Notices: 6 to 10 July 2026</title>
  <description></description>
  <author>Medicines and Healthcare products Regulatory Agency (MHRA)</author>
  <link>https://patient.info/doctor/drug-device-alert/field-safety-notices-6-to-10-july-2026</link>
  <guid>3tcmWwOQjXvOHFZcHrPC2L</guid>
  <pubDate>2026-07-14T09:19:00.000Z</pubDate>
  <enclosure 
    url="https://ogcdn.net/9d266224-4307-4b9d-b73f-00c1bdbd4759/v9/Field%20Safety%20Notices%3A%206%20to%2010%20July%202026/rgba(188%2C%2049%2C%20123%2C%201)/og.png" 
    type="image/jpeg" 
    length="0" />
</item>

        <item>
  <title>Class 2 Medicines Recall: Beckton Dickson UK Ltd, ChloraPrep 1mL applicator, EL(26)A/34</title>
  <description></description>
  <author>Medicines and Healthcare products Regulatory Agency (MHRA)</author>
  <link>https://patient.info/doctor/drug-device-alert/class-2-medicines-recall-beckton-dickson-uk-ltd-chloraprep-1ml-applicator-el-26-a-slash-34</link>
  <guid>1SmFrPRBLLjMh1UnZcpYFs</guid>
  <pubDate>2026-07-13T12:03:35.000Z</pubDate>
  <enclosure 
    url="https://ogcdn.net/9d266224-4307-4b9d-b73f-00c1bdbd4759/v9/Class%202%20Medicines%20Recall%3A%20Beckton%20Dickson%20UK%20Ltd%2C%20ChloraPrep%201mL%20applicator%2C%20EL(26)A%2F34/rgba(188%2C%2049%2C%20123%2C%201)/og.png" 
    type="image/jpeg" 
    length="0" />
</item>

  </channel>
</rss>